Add To My Watchlist
View My Watchlist

Green Zone Power Rating: 24 Bearish

Bearish stocks are expected to underperform the market over the next 12 months.
24
Price Based
Momentum
36
Size
90
Volatility
41
Fundamental Based
Value
38
Quality
15
Growth
10
Positive Factors (Top 20%)
Size: Small-company stocks tend to outperform large-company stocks.
Negative Factors (Bottom 20%)
Quality: Stocks of the lowest quality are exposed to high operational and financial risk.
Growth: Stocks of the lowest-growth companies typically underperform the market.
Collapse Detail
NASDAQ%3AZYME charts & data provided by TradingView

Latest Insights on ZYME

health care stocks Eli Lilly stock LLY Zymeworks stock A 100-Rated Co. Making Huge Strides in the Cancer Fight
by Matthew Clark March 31, 2023 Money & Markets Daily
Despite incredible advances in medicine, cancer is affecting millions. This company is working on a cure.
psychedelic ETF PSYK stocks Psychedelic ETF Deep Dive: 3 Stocks Outperform Market
by Matthew Clark February 25, 2022 Markets
In this week's Marijuana Market Update: Matt looks at three stocks contained within the PSYK Psychedelic ETF. Are they all buys?
next-week-dow Money & Markets Week Ahead Money & Markets Week Ahead: What to Watch on Wall Street
by Matthew Clark August 29, 2020 Markets
In this week's Money & Markets Week Ahead: the Dow Jones Industrial Average's major change, health care IPOs, earnings and more.